We have some exciting news to share! The Motley Fool UK has now become an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. We’ll be introducing a new name and brand over the coming weeks — we're very excited to share it with you and embark on this new chapter together!

3 ISA Buys With Big Growth Potential? GlaxoSmithKline plc, easyJet plc, And SKY PLC

Will GlaxoSmithKline plc (LON:GSK), easyJet plc (LON:EZJ) and SKY PLC (LON:SKY) boost your ISA profits next year?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With only two more trading days left until the end of the tax year, it’s not too late to top up your ISA with some high-quality dividend growth stocks. In today’s article I’ll look at three major companies and ask whether these big cap stocks have the potential to deliver big growth.

An unbeatable buy?

GlaxoSmithKline (LSE: GSK) is one of the largest holdings in my personal portfolio, so I may be biased. But I don’t think I’m wrong.

The UK’s largest pharma stock has now completed a restructuring programme which saw it generate £2bn of sales from new products last year. That total is expected to reach £6bn by 2018. Alongside this, Glaxo expects to deliver £3bn of annual cost savings by 2017.

The result should be a leaner business with improved growth potential. The company will also get a new chief executive in March 2017, when current boss Sir Andrew Witty is set to retire.

In the meantime, Glaxo’s 80p per share dividend gives a yield of 5.7%. Net debt has fallen and earnings are expected to rise this year, making Glaxo’s generous dividend look more affordable than it did last year. In my view, now could be a very good time to build a long-term holding in GlaxoSmithKline.

Flying high, but for how long?

Shares in budget airline easyJet (LSE: EZJ) have fallen by 13% so far this year and by 20% over the last twelve months. The falls have come despite the group reporting rising passenger numbers, stable sales and rising profits.

easyJet’s adjusted earnings per share are expected to rise by 7% this year to 148.4p. This puts the stock on a forecast P/E of 10. There’s also an attractive 65.6p forecast dividend, giving a potential yield of 4.3%.

Current forecasts suggest that earnings growth will accelerate in 2017. Analysts have pencilled in a solid 15% rise in earnings to 170.7p per share.

So why does easyJet seem to be so cheap? One reason is that the airline industry is notoriously cyclical. easyJet shares have risen by 320% over the last five years, during which profits have more than doubled.  It may be that the market is pricing in a slowdown in this rate of growth. Other airline shares have also cooled this year.

However, easyJet’s valuation doesn’t seem demanding. The low-cost model seems to be here to stay. I’m tempted to say that at around 1,500p, easyJet could be a profitable buy.

An uncertain picture

Between October and December 2015, a whopping 337,000 new customers joined Sky (LSE: SKY), the highest level of UK and Ireland growth for ten years.

However, this influx of new customers isn’t expected to result in a surge in profits this year. Current forecasts suggest that Sky’s earnings per share will fall by 9.5% to 62p for the year ending 30 June. A further 7.3% decline is forecast for 2016/17.

One reason for this may be the short-term cost of reducing the group’s £6bn net debt, which is largely the result of Sky’s acquisition of Sky Deutschland and Sky Italia in 2014. Sky has always generated a lot of free cash flow, but reducing the group’s debt will still be a demanding challenge.

Given Sky’s high gearing and the lacklustre outlook for earnings growth, I’m tempted to tune in elsewhere. Sky’s forecast P/E of 16.5 and the firm’s 3.4% forecast dividend don’t seem like bargains to me.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline and Sky. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

2 UK shares to consider avoiding as the FTSE 100 extends losses

As the FTSE 100 dips for the second time this year, Mark Hartley weighs up market sentiment and considers two…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

How to invest £125 a month in UK shares to target a £39,039 annual passive income

Muhammad Cheema explains how an investor could earn the current median salary in the UK as passive income by making…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

These white-hot FTSE 250 growth shares are on sale today!

Royston Wild loves a good bargain. Here he reveals two FTSE 250 shares that all savvy UK stock investors should…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

How much do you need an ISA for a £31,352 second income?

Investing regularly in a Stocks and Shares ISA can generate a significant second income in retirement. Royston Wild explains how.

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

With the Aston Martin share price in pennies, is it in bargain territory?

With the Aston Martin share price at a fraction of what it once was, is it a bargain? Our writer…

Read more »

A hiker and their dog walking towards the mountain summit of High Spy from Maiden Moor at sunrise
Investing Articles

How I plan to lock in sustainable growth on the FTSE 100 in the coming years

Mark Hartley takes a sobering look at the future, and outlines a plan to target FTSE 100 sectors with lower…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

What are the FTSE’s most lucrative high-yield shares?

Our writer zooms in one one of a handful of high-yield FTSE 100 shares to explain why he thinks it…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

Why bother with a SIPP now rather than wait 10 years?

Interested in a SIPP but putting it off to give yourself time to think? Christopher Ruane explains why that could…

Read more »